Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-26-000073
Filing Date
2026-01-06
Accepted
2026-01-06 16:27:01
Documents
1
Period of Report
2026-01-02

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 6335
  Complete submission text file 0000905148-26-000073.txt   7730
Mailing Address C/O METABOLIX, INC. 21 ERIE STREET CAMBRIDGE MA 02139
Business Address
Strobeck Matthew (Reporting) CIK: 0001377832 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39659 | Film No.: 26511966

Mailing Address 919 WEST DILLON ROAD LOUISVILLE CO 80027
Business Address 919 WEST DILLON ROAD LOUISVILLE CO 80027 303-417-0500
BIODESIX INC (Issuer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)